IAnthus Financial Statements From 2010 to 2024
| ITHUF Stock | USD 0 0.0002 4.00% |
Check IAnthus Capital financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IAnthus Capital's main balance sheet or income statement drivers, such as , as well as many indicators such as . IAnthus financial statements analysis is a perfect complement when working with IAnthus Capital Valuation or Volatility modules.
IAnthus |
iAnthus Capital Holdings Company Profit Margin Analysis
IAnthus Capital's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current IAnthus Capital Profit Margin | (2.49) % |
Most of IAnthus Capital's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, iAnthus Capital Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, iAnthus Capital Holdings has a Profit Margin of -2.4882%. This is 77.8% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is 95.92% higher than that of the company.
iAnthus Capital Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IAnthus Capital's current stock value. Our valuation model uses many indicators to compare IAnthus Capital value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IAnthus Capital competition to find correlations between indicators driving IAnthus Capital's intrinsic value. More Info.iAnthus Capital Holdings is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IAnthus Capital's earnings, one of the primary drivers of an investment's value.About IAnthus Capital Financial Statements
IAnthus Capital stakeholders use historical fundamental indicators, such as IAnthus Capital's revenue or net income, to determine how well the company is positioned to perform in the future. Although IAnthus Capital investors may analyze each financial statement separately, they are all interrelated. For example, changes in IAnthus Capital's assets and liabilities are reflected in the revenues and expenses on IAnthus Capital's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in iAnthus Capital Holdings. Please read more on our technical analysis and fundamental analysis pages.
iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. The company was founded in 2014 and is headquartered in New York, New York. Ianthus Capital operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in IAnthus Pink Sheet
IAnthus Capital financial ratios help investors to determine whether IAnthus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IAnthus with respect to the benefits of owning IAnthus Capital security.